SEC FORM 3

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

CHA ALBERT

(Last)

(First)

(Middle)

C/O BIODEL INC

6 CHRISTOPHER COLUMBUS AVENUE

(Street)

DANBURY

06810

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
05/10/2007

3. Issuer Name and Ticker or Trading Symbol
Biodel Inc [ BIOD ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	318	D
Common Stock	606,699	I	See footnote⁽¹⁾

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Director Stock Option (right to buy)	⁽²⁾	07/10/2014	Common Stock	17,713	$5.65	D
Director Stock Option (right to buy)	⁽³⁾	11/30/2014	Common Stock	2,601	$12.63	D
Director Stock Option (right to buy)	05/10/2007	05/09/2017	Common Stock	25,000	$15	D
Series B Convertible Preferred Stock	⁽⁴⁾	⁽⁴⁾	Common Stock	1,078,933	⁽⁵⁾	I	See footnote⁽⁶⁾

Explanation of Responses:

1. Includes 605,729 shares of the Issuer's Common Stock held by Vivo Ventures V Fund, L.P. and 970 shares of the Issuer's Common Stock held by Vivo Ventures V Affiliates Fund, LP. Dr. Cha is a managing partner of Vivo Ventures V, L.P. and may be deemed to beneficially own these shares. The Reporting Person disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein.

2. This option is exercisable in two equal installments on July 11, 2007 and July 11, 2008.

3. This option is exercisable in two equal installments on December 1, 2007 and December 1, 2008.

4. The Series B Convertible Preferred Stock has no expiration date. It is immediately convertible and will automatically convert into Common Stock of the Issuer upon the close of the Issuer's public offering.

5. The shares are convertible on a one for one basis.

6. Includes 1,066,418 shares of the Issuer's Common Stock held by Vivo Ventures Fund V, LP and 12,515 shares of the Issuer's Common Stock held by Vivo Ventures V Affiliates Fund, L.P. Dr. Cha is a managing partner of Vivo Ventures V, L.P. and may be deemed to beneficially own these shares. The Reporting Person disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein.

	/s/ Albert Cha	05/10/2007
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.